---
figid: PMC9609752__metabolites-12-00902-g001
pmcid: PMC9609752
image_filename: metabolites-12-00902-g001.jpg
figure_link: /pmc/articles/PMC9609752/figure/metabolites-12-00902-f001/
number: Figure 1
figure_title: ''
caption: The metabolic pathway for tyrosine catabolism in humans and experimental
  animals, showing the enzymes involved, the known sites of inborn errors in metabolism
  and the site of action of the drug Nitisinone used to treat tyrosinaemia type 1
  and alkaptonuria.
article_title: The Discovery of the Mode of Action of Nitisinone.
citation: Edward A. Lock. Metabolites. 2022 Oct;12(10):902.
year: '2022'

doi: 10.3390/metabo12100902
journal_title: Metabolites
journal_nlm_ta: Metabolites
publisher_name: MDPI

keywords:
- Nitisinone
- 4-hydroxyphenylpyruvate dioxygenase
- tyrosinaemia type1
- alkaptonuria

---
